Aerobic exercise program for older adults with mild cognitive impairment
Official title: Precision Medicine in Alzheimer's Disease: A SMART Trial of Adaptive Exercises and Their Mechanisms of Action Using AT(N) Biomarkers to Optimize Aerobic-Fitness Responses (The FIT-AD SMART Trial)
Run by Arizona State University · NCT05877196 · Data updated 2026-11-12
This study is testing if a 6-month aerobic exercise program can help older adults with mild cognitive impairment or early Alzheimer's improve their brain health and fitness.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 216 (estimated) |
| Sponsor | Arizona State University Academic / other |
| Locations | 1 site (Phoenix, Arizona) |
| Status | Recruiting |
| Started | June 22, 2023 |
| Main results expected | April 1, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT05877196 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are community-dwelling adults aged 65 and older with a clinical diagnosis of mild cognitive impairment or early Alzheimer's disease.
✕Probably not a fit
Patients with significant cardiac issues or those currently enrolled in other cognitive improvement interventions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effects of a 6-month aerobic exercise program on older adults aged 65 and above who have mild cognitive impairment or early Alzheimer's disease. Participants will engage in various exercise interventions, including moderate intensity continuous training and high-intensity interval training, while undergoing cognitive assessments and MRI scans to monitor changes in brain health and fitness levels. The study seeks to identify the most effective exercise regimen for improving aerobic fitness and cognitive outcomes, as well as to explore the underlying mechanisms of exercise on memory function. Monthly follow-ups will provide additional support and health discussions for participants throughout the trial.
Why it matters
Potential benefit: If successful, this program could enhance aerobic fitness and cognitive function in older adults, potentially slowing the progression of Alzheimer's disease.
How similar studies have gone: Previous studies have shown mixed results regarding the effects of aerobic exercise on cognitive function in dementia, indicating that while some approaches have been beneficial, this specific adaptive exercise methodology is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants: * Clinical diagnosis of MCI or probable and possible mild AD dementia according to 2011 Alzheimer's association-NIA criteria. * Community-dwelling, e.g., homes and assisted living * Age 65 years and older * Medical clearance from PCP or cardiovascular provider * Have a qualified study partner * Agree to the blood draws * Verified MRI safety Study Partner: * Age 18 or older * Contact with participant ≥ 2 times per week for ≥ 6 months * Know the participant's memory status and ability to perform activities of daily living * Consent to participant Exclusion Criteria: Participants * Resting HR ≤ 50 or ≥ 100 beats/min after 5-minutes of quiet resting * American College of Sports Medicine contraindications to exercise * New, unevaluated symptoms or diseases a healthcare provider has not evaluated * Abnormal cardiac condition uncovered during VO2peak testing * Enrollment in another intervention that aims at improving cognition * Moderate to strenuous exercise ≥150 minutes a week in the previous 6 months * ≥ 2 anti-depression medications, or poorly managed or unstable depression * Poorly managed or unstable anxiety Study partners: * none
Where it's running
-
Arizona State University
Phoenix, Arizona, United States Recruiting
Study contacts
- Principal investigator: Fang Yu, PhD — Arizona State University
- Study coordinator: Kristi Spieleder, MS
- Email: kspieled@asu.edu
- Phone: 480-884-2765
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease
A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.
-
Using brain stimulation and digital training to improve cognitive function in older adults
This study is testing whether a combination of brain stimulation and digital training can help improve thinking skills in older adults with Mild Cognitive Impairment and Alzheimer's Disease.
-
Investigating biomarkers related to Alzheimer's disease and cognitive impairment
This study is trying to see how blood tests and brain scans relate to Alzheimer's disease and memory issues in older adults aged 60 to 90.
-
Using lithium to prevent cognitive decline after brain radiotherapy in children
This study is testing if taking lithium can help prevent memory and thinking problems in children who have survived brain tumors and received radiation therapy.
-
Investigating the relationship between white matter hyperintensity shape and brain clearance in dementia
This study is trying to see how the shape of certain brain changes in older adults with small vessel disease relates to their thinking skills and dementia.
-
Exploring brain mechanisms related to personal memory
This study is testing how brain activity related to personal memories works in people with mild cognitive impairment compared to healthy older and younger adults, and whether a special brain stimulation can change this activity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.